Advancements in CRISPR-Cas9 Technology for Genome Editing

Authors

  • Adrian Davis PhD
  • Ashley Young Dr.
  • Quinn Taylor Prof.

Keywords:

CRISPR-Cas9, Genome editing, Genetic disorders, Targeting specificity, Therapeutic applications

Abstract

CRISPR-Cas9 technology has revolutionized genome editing by providing a precise and efficient method for altering genetic sequences. This article reviews recent advancements in CRISPR-Cas9 applications, highlighting innovations in targeting specificity and delivery methods. We discuss the implications of these advancements for therapeutic applications, including the potential for correcting genetic disorders and improving crop resistance. The ethical considerations and challenges associated with CRISPR-Cas9 technology are also addressed.

Author Biographies

Adrian Davis, PhD

PhD
University of Auckland
Auckland 1010, New Zealand

Ashley Young, Dr.

Dr.
University of Helsinki
Yliopistonkatu 4, 00100 Helsinki, Finland

Quinn Taylor, Prof.

Prof.
University of Vienna
Universitätsring 1, 1010 Wien, Austria

References

Sharma, V. K., Basu, S., & Chakraborty, S. (2015). RNAi mediated broad-spectrum transgenic resistance in Nicotiana benthamiana to chilli-infecting begomoviruses. Plant cell reports, 34(8), 1389-1399.

Kumar, R. V., Sharma, V. K., Chattopadhyay, B., & Chakraborty, S. (2012). An improved plant regeneration and Agrobacterium-mediated transformation of red pepper (Capsicum annuum L.). Physiology and Molecular Biology of Plants, 18(4), 357-364.

Downloads

Published

2024-08-15

Issue

Vol. 2 No. 3 (2024)

Section

Articles